Drawing for SWAB-N-GO

USPTO serial 97477622

SWAB-N-GO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FICKES, JERI J
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SWAB-N-GO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jun-Hwa Jeong

Jun-Hwa Jeong RABIN & BERDO, P.C.2650 PARK TOWER DRIVE, SUITE 800VIENNA, VA 22180UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological samples in the nature preparation for use in cell cultures and tissue cultures for scientific or research use; reagents for scientific or research use; reagents for processing biological samples in the nature preparation for use in cell cultures and tissue cultures for scientific or research use; immunoassay reagents for scientific or research use; molecular diagnosis reagents for scientific or research use; biological reagents for scientific or research use; testing reagents for biological samples in the nature of preparation for use in cell cultures and tissue cultures for scientific or research use; biochemical reagents for scientific or research use; diagnostic reagents for scientific or research use; in vitro diagnostic reagents for scientific or research use; chemical reagents for scientific or research use; molecular diagnosis chemically treated test paper or test strips for scientific or research use, other than for medical or veterinary purposes; analytical reagents for laboratory apparatus for molecular diagnosis, other than for medical or veterinary purposes; chemically treated test paper or test strips for biology or chemistry for scientific or research use, other than for medical or veterinary purposes; test paper or test strips for analyzing biological sample, other than for medical or veterinary purposes; chemically treated test paper or test strips treated with biochemical sample or chemicals, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; chemically treated non-medical test paper or test strips for calibrating laboratory apparatus; chemically treated test paper or test strips for in vitro diagnosis, other than for medical or veterinary purposes; analytical reagents for laboratory apparatus for in vitro diagnosis, other than for medical or veterinary purposes; chemically treated test paper or test strips treated with immunoassay reagents for antigen-antibody reaction, other than for medical or veterinary purposes; immunoassay reagents for antigen-antibody reaction, other than for medical or veterinary purposesACTIVE—
005Diagnostic test paper or test strips for molecular diagnosis for medical purposes; analytical reagents for medical apparatus for molecular diagnosis for medical use; diagnostic test paper or test strips for analyzing biological specimens and chemicals in the biological specimens for medical purposes; diagnostic test paper or test strips for analyzing biological sample for medical purposes; diagnostic test paper or test strips treated with biochemical preparations or chemicals for analysis of body fluids for medical purposes; biochemical reagents for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; biological sample in the nature of body fluids for medical or veterinary purposes; in vitro diagnostic reagents for medical or veterinary purposes; immunoassay reagents for medical or veterinary purposes; molecular diagnosis reagents for medical or veterinary purposes; biological reagents for medical or veterinary purposes; reagents for processing biological sample for medical or veterinary purposes; reagents for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; reagent for testing biological sample for medical or veterinary purposes; reagent paper for medical purposes; medical diagnostic test paper or test strips for clinical laboratory tests for calibrating medical apparatus; diagnostic test paper or test strips for in vitro diagnosis of respiratory diseases; analytical reagents for medical apparatus used for in vitro diagnosis for medical purposes; diagnostic test paper or test strips treated with immunoassay reagents for antigen-antibody reaction for medical use; immunoassay reagents for antigen-antibody reaction for medical purposesACTIVE—
010In vitro diagnosis cartridge for medical purposes, namely, medical diagnostic instruments for the analysis of body fluids; immunoassay cartridge for in vitro diagnosis for medical purposes, namely, medical diagnostic instruments for the analysis of body fluids for medical use; cartridge for testing chemical composition or measuring concentration of test specimen in the nature of liquid biological sample for medical purpose; immunoassay diagnosis cartridge for the analysis of body fluids for medical purposes; cartridge for molecular diagnosis for determining the concentration of target analytes in body fluids for medical purposes; immunoassay cartridge for molecular diagnosis determining the concentration of target analytes in body fluids for medical purposes; cartridge for analyzing biological sample for medical purpose, namely, apparatus for body fluid analysis; medical apparatus, namely, medical imaging apparatus; in vitro diagnostic devices for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 13, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 13, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 20, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 4, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Apr 4, 2023CNSLSUSPENSION LETTER WRITTEN—
Mar 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 1, 2022DOCKASSIGNED TO EXAMINER—
Jul 20, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 30, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance